Editor LSA

Stock's Buzzers: iShares iBoxx $ High Yid Corp Bond (ETF)(NYSEARCA:HYG), Walgreen Company (NYSE:WAG), SPDR Barclays Capital High Yield Bnd ETF (NYSEARCA:JNK), AbbVie Inc (NYSE:ABBV)

 

Lewes, DE -- (SBWIRE) -- 09/12/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: iShares iBoxx $ High Yid Corp Bond (ETF)(NYSEARCA:HYG), Walgreen Company (NYSE:WAG), SPDR Barclays Capital High Yield Bnd ETF (NYSEARCA:JNK), AbbVie Inc (NYSE:ABBV)

iShares iBoxx $ High Yid Corp Bond (ETF)(NYSEARCA:HYG) opened its shares at the price of $90.99 for the day. Its closing price was $91.24 after gaining +0.13% for the day. The company traded with the total volume of 3.51 million shares. The beta of HYG stands at0.64.

Why Should Investors Buy HYG After The Recent Gain? Just Go Here and Find Out

Walgreen Company (NYSE:WAG) percentage change surged +0.16% to close at $50.75 with the total traded volume of 3.48 million shares, and average volume of 3.72 million. The 52 week range of the stock remained $31.88 - $51.62, while its day lowest price was $50.33 and it hit its day highest price at $50.78.

Walgreen Co., together with its subsidiaries, operates a network of drugstores in the United States.

Will WAG Continue To Move Higher? Find Out Here

SPDR Barclays Capital High Yield Bnd ETF (NYSEARCA:JNK) started its trading session with the price of $39.54 and closed at $39.65 by scoring +0.18%. JNK’s stocks traded with total volume of 3.48 million shares. The beta of JNK stands at 0.75. Day range of the stock was $39.51-$39.65.

For How Long JNK’s Gloss will Attract Investors? Find out via this report

AbbVie Inc (NYSE:ABBV) ended its day with the gain of +0.38% and closed at the price of $44.95 after opening at $44.81. Stock traded during its last trading session with the total volume of 3.44 million shares, as compared to its average volume of 3.63 million shares.

AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide.

For How Long ABBV will Fight for Profitability? Read This Trend Analysis report

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/